Foghorn Therapeutics Inc.
Pioneering medicines targeting the chromatin regulatory system to treat genetically defined cancers.
FHTX | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 500 TECHNOLOGY SQUARE, 2139 CAMBRIDGE
- Website:
- https://foghorntx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Foghorn Therapeutics Inc. is a clinical-stage biopharmaceutical company pioneering a new class of medicines that target the chromatin regulatory system to correct abnormal gene expression. The company develops precision therapeutics designed to modulate the system that orchestrates which genes are turned on or off, a process often dysregulated in serious diseases. Leveraging its proprietary Gene Traffic Control® platform, Foghorn is advancing a pipeline of drug candidates, including protein degraders and enzyme inhibitors, with an initial focus on treating genetically defined cancers and the potential to expand into other therapeutic areas.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Foghorn Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Foghorn Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Foghorn Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
